215 related articles for article (PubMed ID: 15767639)
1. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.
Couban S; Goodyear M; Burnell M; Dolan S; Wasi P; Barnes D; Macleod D; Burton E; Andreou P; Anderson DR
J Clin Oncol; 2005 Jun; 23(18):4063-9. PubMed ID: 15767639
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.
Verso M; Agnelli G; Bertoglio S; Di Somma FC; Paoletti F; Ageno W; Bazzan M; Parise P; Quintavalla R; Naglieri E; Santoro A; Imberti D; Sorarù M; Mosca S
J Clin Oncol; 2005 Jun; 23(18):4057-62. PubMed ID: 15767643
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
[TBL] [Abstract][Full Text] [Related]
4. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
van Rooden CJ; Schippers EF; Guiot HF; Barge RM; Hovens MM; van der Meer FJ; Rosendaal FR; Huisman MV
J Clin Oncol; 2008 Jan; 26(3):428-33. PubMed ID: 18202420
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.
Verso M; Agnelli G; Kamphuisen PW; Ageno W; Bazzan M; Lazzaro A; Paoletti F; Paciaroni M; Mosca S; Bertoglio S
Intern Emerg Med; 2008 Jun; 3(2):117-22. PubMed ID: 18317868
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.
Magagnoli M; Masci G; Castagna L; Zucali PA; Morenghi E; Pedicini V; Santoro A
Anticancer Res; 2005; 25(4):3143-7. PubMed ID: 16080578
[TBL] [Abstract][Full Text] [Related]
8. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
Rawson KM; Newburn-Cook CV
Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
[TBL] [Abstract][Full Text] [Related]
9. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.
Young AM; Billingham LJ; Begum G; Kerr DJ; Hughes AI; Rea DW; Shepherd S; Stanley A; Sweeney A; Wilde J; Wheatley K;
Lancet; 2009 Feb; 373(9663):567-74. PubMed ID: 19217991
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study.
Paglialonga F; Artoni A; Braham S; Consolo S; Giannini A; Chidini G; Napolitano L; Martinelli I; Montini G; Edefonti A
Pediatr Nephrol; 2016 May; 31(5):827-32. PubMed ID: 26667238
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic complications of central venous catheters in cancer patients.
Kuter DJ
Oncologist; 2004; 9(2):207-16. PubMed ID: 15047925
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
[TBL] [Abstract][Full Text] [Related]
13. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
[TBL] [Abstract][Full Text] [Related]
14. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
Chan A; Iannucci A; Dager WE
Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
[TBL] [Abstract][Full Text] [Related]
15. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
Karthaus M; Kretzschmar A; Kröning H; Biakhov M; Irwin D; Marschner N; Slabber C; Fountzilas G; Garin A; Abecasis NG; Baronius W; Steger GG; Südhoff T; Giorgetti C; Reichardt P
Ann Oncol; 2006 Feb; 17(2):289-96. PubMed ID: 16317012
[TBL] [Abstract][Full Text] [Related]
16. Thromboprophylaxis of central venous lines in children with cancer: the first steps taken on the long road ahead.
Massicotte P; Mitchell L
Acta Paediatr; 2006 Sep; 95(9):1049-52. PubMed ID: 16938748
[TBL] [Abstract][Full Text] [Related]
17. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.
Heaton DC; Han DY; Inder A
Intern Med J; 2002 Mar; 32(3):84-8. PubMed ID: 11885848
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
Verso M; Agnelli G
J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.
Lee AY; Levine MN; Butler G; Webb C; Costantini L; Gu C; Julian JA
J Clin Oncol; 2006 Mar; 24(9):1404-8. PubMed ID: 16549834
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
